Dmitri Bobilev - Net Worth and Insider Trading

Dmitri Bobilev Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dmitri Bobilev owns 1 companies in total, including Fusion Pharmaceuticals Inc (FUSN) .

Click here to see the complete history of Dmitri Bobilev’s form 4 insider trades.

Insider Ownership Summary of Dmitri Bobilev

Ticker Comapny Transaction Date Type of Owner
FUSN Fusion Pharmaceuticals Inc 2022-11-07 Chief Medical Officer

Dmitri Bobilev Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dmitri Bobilev Ownership Network

Ownership Network List of Dmitri Bobilev

No Data

Ownership Network Relation of Dmitri Bobilev

Insider Network Chart

Dmitri Bobilev Owned Company Details

What does Fusion Pharmaceuticals Inc do?

Who are the key executives at Fusion Pharmaceuticals Inc?

Dmitri Bobilev is the Chief Medical Officer of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include director & Chief Executive Officer John Valliant , Chief Scientific Officer Christopher P Leamon , and President and CBO Mohit Rawat .

Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fusion Pharmaceuticals Inc Insider Transactions

No Available Data

Dmitri Bobilev Mailing Address

Above is the net worth, insider trading, and ownership report for Dmitri Bobilev. You might contact Dmitri Bobilev via mailing address: C/o Fusion Pharmaceuticals Inc., 270 Longwood Rd. South, Hamilton Z4 L8p 0a6.

Discussions on Dmitri Bobilev

No discussions yet.